Literature DB >> 9085230

Crevicular fluid and serum IgG subclasses and corresponding mRNA expressing plasma cells in periodontitis lesions.

D F Kinane1, K Takahashi, J Mooney.   

Abstract

Recent reports suggest that specific serum IgG subclasses are a feature of several forms of periodontitis. GCF antibodies are both serum-derived and locally produced by the abundant plasma cells of the diseased periodontal tissue. Previous work has shown that crevicular fluid (GCF) levels of IgG may be reduced in active and deep periodontal pockets when compared to other sites in chronic periodontitis patients (7). These findings, and more recent findings for IgA levels in GCF (5), suggest that GCF immunoglobulins may indicate "high risk" sites for periodontitis. In these studies, the relative distribution of IgG isotypes was not investigated, nor was the relative contribution of local and serum antibodies to the GCF immunoglobulin profile. Therefore, more precise investigation of the tissue distribution of local gingival IgG subclass producing plasma cells and their protein levels in the GCF from the same sites and in serum, was undertaken.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085230     DOI: 10.1111/j.1600-0765.1997.tb01401.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  3 in total

Review 1.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

2.  Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue.

Authors:  D F Lappin; C P MacLeod; A Kerr; T Mitchell; D F Kinane
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Cleavage of IgG1 in gingival crevicular fluid is associated with the presence of Porphyromonas gingivalis.

Authors:  A Guentsch; C Hirsch; W Pfister; B Vincents; M Abrahamson; A Sroka; J Potempa; S Eick
Journal:  J Periodontal Res       Date:  2012-11-01       Impact factor: 4.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.